First Trust Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $124M | Sell |
|
|||||
|
2021
Q1 | $110M | Sell |
|
|||||
|
2020
Q4 | $120M | Sell |
|
|||||
|
2020
Q3 | $245M | Buy |
|
|||||
|
2020
Q2 | $220M | Buy |
|
|||||
|
2020
Q1 | $86.9M | Buy |
|
|||||
|
2019
Q4 | $91.7M | Buy |
|
|||||
|
2019
Q3 | $64.6M | Sell |
|
|||||
|
2019
Q2 | $128M | Buy |
|
|||||
|
2019
Q1 | $124M | Buy |
|
|||||
|
2018
Q4 | $87.7M | Buy |
|
|||||
|
2018
Q3 | $123M | Buy |
|
|||||
|
2018
Q2 | $67.1M | Buy |
|
|||||
|
2018
Q1 | $53.7M | Sell |
|
|||||
|
2017
Q4 | $60M | Buy |
|
|||||
|
2017
Q3 | $45.6M | Sell |
|
|||||
|
2017
Q2 | $39.9M | Buy |
|
|||||
|
2017
Q1 | $34.7M | Buy |
|
|||||
|
2016
Q4 | $32.9M | Buy |
|
|||||
|
2016
Q3 | $31.6M | Buy |
|
|||||
|
2016
Q2 | $27.2M | Sell |
|
|||||
|
2016
Q1 | $57.8M | Sell |
|
|||||
|
2015
Q4 | $150M | Sell |
|
|||||
|
2015
Q3 | $127M | Buy |
|
|||||
|
2015
Q2 | $144M | Sell |
|
|||||
|
2015
Q1 | $165M | Buy |
|
|||||
|
2014
Q4 | $135M | Buy |
|
|||||
|
2014
Q3 | $117M | Sell |
|
|||||
|
2014
Q2 | $120M | Buy |
|
|||||
|
2014
Q1 | $103M | Buy |
|
|||||
|
2013
Q4 | $75.6M | Buy |
|
|||||
|
2013
Q3 | $45.8M | Buy |
|
|||||
|
2013
Q2 | $27M | Buy |
|